Methotrexate oral solution - Silvergate Pharmaceuticals

Drug Profile

Methotrexate oral solution - Silvergate Pharmaceuticals

Alternative Names: Methotrexate oral liquid - Silvergate Pharmaceuticals; Methotrexate sodium - Silvergate Pharmaceuticals; XATMEP

Latest Information Update: 03 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Silvergate Pharmaceuticals
  • Class Abortifacients; Antiasthmatics; Antineoplastics; Antipsoriatics; Antirheumatics; Benzamides; Disease-modifying antirheumatics; Glutamates; Pterins; Small molecules
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors; Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Juvenile rheumatoid arthritis; Precursor cell lymphoblastic leukaemia-lymphoma
  • New Molecular Entity No

Highest Development Phases

  • Marketed Juvenile rheumatoid arthritis; Precursor cell lymphoblastic leukaemia-lymphoma

Most Recent Events

  • 25 May 2017 Chemical structure information added
  • 26 Apr 2017 Launched for Acute lymphoblastic leukaemia (Combination therapy, In adolescents, In children, In infants, In neonates) in USA (PO)
  • 26 Apr 2017 Launched for Juvenile rheumatoid arthritis (In adolescents, In children, In infants, In neonates, Treatment-experienced) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top